| Kalim Ahmed, MD | |
|
12821 Oak Hill Ave, Hagerstown, MD 21742-2940 | |
| (301) 733-0300 | |
| (301) 733-5773 |
| Full Name | Kalim Ahmed |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 28 Years |
| Location | 12821 Oak Hill Ave, Hagerstown, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194709204 | NPI | - | NPPES |
| 402982802 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | MD058726L (Pennsylvania) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | D6028 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Meritus Medical Center | Hagerstown, MD | Hospital |
| Waynesboro Hospital | Waynesboro, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Practices Of Antietam, Llc | 2567353865 | 184 |
| Medical Practices Of Antietam, Llc | 2567353865 | 184 |
News Archive
DNA Heritage has recently overcome patent claims held by a competitor which would have severely restricted the use of DNA testing and databases that allow families around the world to match and connect up through their DNA.
A new therapy for influenza virus infections that may also prove effective against many other pathogenic virus infections, including HIV and COVID-19, has been developed by Purdue University scientists.
Abbott today announced that it has received U.S. Food and Drug Administration (FDA) clearance for the FreeStyle InsuLinx Blood Glucose Monitoring System, the first from Abbott to include a touch-screen interface, automated logbook and several personalization features designed to improve the diabetes management experience for patients.
Rush University Medical Center is among the first hospitals in the nation, and the only one in Illinois, to provide patients fighting advanced kidney access to a new combination immunotherapy that targets different immune system cells and processes than a widely used therapy that has been proven effective for some patients but had little effect on others.
In a new report published in the Journal of Leukocyte Biology, scientists lay the groundwork for the development of novel tumor therapies that may help rid the body of cancer by inhibiting the recruitment of a specific suppressive immune cell type called "regulatory T-cells." The approach described in the report shows that an immune molecule, called interleukin-27, promotes the recruitment of regulatory T-cells.
› Verified 4 days ago
| Entity Name | Drs. Waheed Alencherry And Iqbal Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295719599 PECOS PAC ID: 8022919380 Enrollment ID: O20040119000629 |
News Archive
DNA Heritage has recently overcome patent claims held by a competitor which would have severely restricted the use of DNA testing and databases that allow families around the world to match and connect up through their DNA.
A new therapy for influenza virus infections that may also prove effective against many other pathogenic virus infections, including HIV and COVID-19, has been developed by Purdue University scientists.
Abbott today announced that it has received U.S. Food and Drug Administration (FDA) clearance for the FreeStyle InsuLinx Blood Glucose Monitoring System, the first from Abbott to include a touch-screen interface, automated logbook and several personalization features designed to improve the diabetes management experience for patients.
Rush University Medical Center is among the first hospitals in the nation, and the only one in Illinois, to provide patients fighting advanced kidney access to a new combination immunotherapy that targets different immune system cells and processes than a widely used therapy that has been proven effective for some patients but had little effect on others.
In a new report published in the Journal of Leukocyte Biology, scientists lay the groundwork for the development of novel tumor therapies that may help rid the body of cancer by inhibiting the recruitment of a specific suppressive immune cell type called "regulatory T-cells." The approach described in the report shows that an immune molecule, called interleukin-27, promotes the recruitment of regulatory T-cells.
› Verified 4 days ago
| Entity Name | Fulton County Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326044694 PECOS PAC ID: 6406841295 Enrollment ID: O20040420000435 |
News Archive
DNA Heritage has recently overcome patent claims held by a competitor which would have severely restricted the use of DNA testing and databases that allow families around the world to match and connect up through their DNA.
A new therapy for influenza virus infections that may also prove effective against many other pathogenic virus infections, including HIV and COVID-19, has been developed by Purdue University scientists.
Abbott today announced that it has received U.S. Food and Drug Administration (FDA) clearance for the FreeStyle InsuLinx Blood Glucose Monitoring System, the first from Abbott to include a touch-screen interface, automated logbook and several personalization features designed to improve the diabetes management experience for patients.
Rush University Medical Center is among the first hospitals in the nation, and the only one in Illinois, to provide patients fighting advanced kidney access to a new combination immunotherapy that targets different immune system cells and processes than a widely used therapy that has been proven effective for some patients but had little effect on others.
In a new report published in the Journal of Leukocyte Biology, scientists lay the groundwork for the development of novel tumor therapies that may help rid the body of cancer by inhibiting the recruitment of a specific suppressive immune cell type called "regulatory T-cells." The approach described in the report shows that an immune molecule, called interleukin-27, promotes the recruitment of regulatory T-cells.
› Verified 4 days ago
| Entity Name | Medical Practices Of Antietam, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558430843 PECOS PAC ID: 2567353865 Enrollment ID: O20210914002778 |
News Archive
DNA Heritage has recently overcome patent claims held by a competitor which would have severely restricted the use of DNA testing and databases that allow families around the world to match and connect up through their DNA.
A new therapy for influenza virus infections that may also prove effective against many other pathogenic virus infections, including HIV and COVID-19, has been developed by Purdue University scientists.
Abbott today announced that it has received U.S. Food and Drug Administration (FDA) clearance for the FreeStyle InsuLinx Blood Glucose Monitoring System, the first from Abbott to include a touch-screen interface, automated logbook and several personalization features designed to improve the diabetes management experience for patients.
Rush University Medical Center is among the first hospitals in the nation, and the only one in Illinois, to provide patients fighting advanced kidney access to a new combination immunotherapy that targets different immune system cells and processes than a widely used therapy that has been proven effective for some patients but had little effect on others.
In a new report published in the Journal of Leukocyte Biology, scientists lay the groundwork for the development of novel tumor therapies that may help rid the body of cancer by inhibiting the recruitment of a specific suppressive immune cell type called "regulatory T-cells." The approach described in the report shows that an immune molecule, called interleukin-27, promotes the recruitment of regulatory T-cells.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kalim Ahmed, MD 12821 Oak Hill Ave, Hagerstown, MD 21742-2940 Ph: (301) 733-0300 | Kalim Ahmed, MD 12821 Oak Hill Ave, Hagerstown, MD 21742-2940 Ph: (301) 733-0300 |
News Archive
DNA Heritage has recently overcome patent claims held by a competitor which would have severely restricted the use of DNA testing and databases that allow families around the world to match and connect up through their DNA.
A new therapy for influenza virus infections that may also prove effective against many other pathogenic virus infections, including HIV and COVID-19, has been developed by Purdue University scientists.
Abbott today announced that it has received U.S. Food and Drug Administration (FDA) clearance for the FreeStyle InsuLinx Blood Glucose Monitoring System, the first from Abbott to include a touch-screen interface, automated logbook and several personalization features designed to improve the diabetes management experience for patients.
Rush University Medical Center is among the first hospitals in the nation, and the only one in Illinois, to provide patients fighting advanced kidney access to a new combination immunotherapy that targets different immune system cells and processes than a widely used therapy that has been proven effective for some patients but had little effect on others.
In a new report published in the Journal of Leukocyte Biology, scientists lay the groundwork for the development of novel tumor therapies that may help rid the body of cancer by inhibiting the recruitment of a specific suppressive immune cell type called "regulatory T-cells." The approach described in the report shows that an immune molecule, called interleukin-27, promotes the recruitment of regulatory T-cells.
› Verified 4 days ago
Sadik Mohammed Ali, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 251 E Antietam St, Hagerstown, MD 21740 Phone: 301-790-8804 | |
Dr. Alida Mercedes Espinoza, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1130 Opal Ct, Hagerstown, MD 21740 Phone: 301-797-8279 Fax: 301-797-8504 | |
Dr. James E Cremins, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 11110 Medical Campus Rd, Suite 242, Hagerstown, MD 21742 Phone: 240-382-3783 Fax: 240-382-3799 | |
Jason Slack, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 11116 Medical Campus Rd, Hagerstown, MD 21742 Phone: 301-790-8804 | |
Fahad Lodhi, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1733 Howell Rd, Hagerstown, MD 21740 Phone: 301-797-2525 | |
Dr. Tarek Nabil El-sherif, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 11110 Medical Campus Rd, # 223, Hagerstown, MD 21742 Phone: 301-560-4747 Fax: 301-776-1725 | |
Khetisuda Suvarnasuddhi, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 12931 Oak Hill Ave, Hagerstown, MD 21742 Phone: 301-797-9600 Fax: 301-797-3854 |